Novacyt recovers £12.2m in VAT after settling DHSC dispute
![Novacyt Group | Sharecast graphic / Josh White dl novacyt group aim clinical diagnostics testing coronavirus covid 19 pcr rapid laboratory lab logo](https://img1.s3wfg.com/web/img/images_uploaded/d/3/dl-novacyt-group-aim-clinical-diagnostics-testing-coronavirus-covid-19-pcr-rapid-laboratory-lab-logo_620x350.jpg)
Novacyt S.A. (CDI)
69.90p
16:34 12/09/24
Molecular diagnostics company Novacyt announced the successful recovery of £12.2m in VAT from HM Revenue and Customs (HMRC) on Thursday.
FTSE AIM All-Share
741.36
17:04 12/09/24
Health Care Equipment & Services
11,785.09
17:14 12/09/24
The firm said it had already received the full amount, boosting its financial position.
It said the VAT reclaim was related to invoices issued to the UK Department of Health and Social Care (DHSC), which would no longer be paid following a recent dispute settlement.
As previously reported in the company's annual general meeting statement on 18 July, Novacyt said it had sought to reclaim the VAT as part of its financial strategy following the resolution of the dispute.
After settling the dispute, which included a £5m payment to the DHSC in early July, Novacyt's net cash position had improved by over £7m.
At 1446 BST, shares in Novacyt were up 24.45% at 112.5p.
Reporting by Josh White for Sharecast.com.